We are live on
!
Find out more
Calamos Advisors Portfolio holdings
AUM
$28.2B
1-Year Est. Return
21.78%
This Fund
S&P 500
This Quarter
Est. Return
+17.1%
1 Year Est. Return
+21.78%
3 Year Est. Return
+69.57%
5 Year Est. Return
+92%
10 Year Est. Return
+282.63%
AUM
$14.1B
AUM Growth
+$1.4B
(+11%)
Cap. Flow
-$4.28B
Cap. Flow
% of AUM
-30.25%
Top 10 Holdings %
Top 10 Hldgs %
20.4%
Holding
803
New
108
Increased
91
Reduced
295
Closed
98
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
BSX.PRA
Boston Scientific Corporation 5.50% Mandatory Convertible Preferred Stock, Series A
BSX.PRA
|
+$61M |
| 2 |
RTX Corp
RTX
|
+$38.2M |
| 3 |
Vertex Pharmaceuticals
VRTX
|
+$15.5M |
| 4 |
Delta Air Lines
DAL
|
+$14.5M |
| 5 |
SWT
Stanley Black & Decker, Inc.
SWT
|
+$13.9M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$578M |
| 2 |
AGN
Allergan plc
AGN
|
+$67M |
| 3 |
BDXA
Becton, Dickinson and Company Depositary Shares, each Representing a 1/20th Interest in a Share of 6
BDXA
|
+$51.1M |
| 4 |
Alibaba
BABA
|
+$46.8M |
| 5 |
lululemon athletica
LULU
|
+$42M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 14.91% |
| 2 | Healthcare | 8.15% |
| 3 | Consumer Discretionary | 7.49% |
| 4 | Financials | 7.2% |
| 5 | Communication Services | 5.9% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
K
251
DELISTED
Kellanova
K
| $7.21M | 0.05% |
116,319
-7,443
| -6% | -$450K |
|
252
Consolidated Edison
ED
$41.3B
| $7.13M | 0.05% |
99,185
-6,347
| -6% | -$487K |
|
253
PACCAR
PCAR
$72.7B
| $7.13M | 0.05% |
142,806
-9,138
| -6% | -$427K |
|
254
Digital Realty Trust
DLR
$71.5B
| $7.09M | 0.05% |
49,900
-3,193
| -6% | -$452K |
|
255
Las Vegas Sands
LVS
$32B
| $7.06M | 0.05% |
+155,101
| New | +$7.29M |
|
256
Ross Stores
ROST
$80.5B
| $7.04M | 0.05% |
82,568
-5,283
| -6% | -$479K |
|
257
iShares Core S&P 500 ETF
IVV
$871B
| $6.99M | 0.05% |
22,566
-2,251
| -9% | -$661K |
|
258
Assurant
AIZ
$14B
| $6.98M | 0.05% |
67,579
-4,484
| -6% | -$464K |
|
259
Regeneron Pharmaceuticals
REGN
$72.9B
| $6.95M | 0.05% |
11,140
-712
| -6% | -$404K |
|
260
CMS Energy
CMS
$23B
| $6.92M | 0.05% |
118,464
-7,580
| -6% | -$439K |
|
|
RDFN
261
DELISTED
Redfin
RDFN
| $6.85M | 0.05% |
163,506
+19,652
| +14% | +$518K |
|
262
Travelers Companies
TRV
$82.9B
| $6.85M | 0.05% |
60,092
-3,844
| -6% | -$405K |
|
263
Church & Dwight Co
CHD
$23.7B
| $6.8M | 0.05% |
88,028
-5,581
| -6% | -$406K |
|
264
Entergy
ETR
$52.4B
| $6.8M | 0.05% |
145,052
-9,280
| -6% | -$451K |
|
265
Ameriprise Financial
AMP
$48.3B
| $6.76M | 0.05% |
45,052
-2,883
| -6% | -$370K |
|
266
Centene
CNC
$31.6B
| $6.75M | 0.05% |
106,150
-6,792
| -6% | -$442K |
|
267
Nokia
NOK
$49.9B
| $6.69M | 0.05% |
1,520,000
| – | – |
|
268
Cognizant
CTSH
$23.8B
| $6.68M | 0.05% |
117,589
-7,523
| -6% | -$404K |
|
269
Amphenol
APH
$177B
| $6.66M | 0.05% |
278,028
-17,788
| -6% | -$397K |
|
270
Kroger
KR
$36.3B
| $6.62M | 0.05% |
195,574
-12,037
| -6% | -$390K |
|
271
AvalonBay Communities
AVB
$27.2B
| $6.5M | 0.05% |
42,058
-2,691
| -6% | -$426K |
|
272
McKesson
MCK
$104B
| $6.46M | 0.05% |
42,086
-2,693
| -6% | -$389K |
|
273
Paychex
PAYX
$42.3B
| $6.43M | 0.05% |
84,868
-5,431
| -6% | -$376K |
|
|
ZYXI
274
DELISTED
Zynex
ZYXI
| $6.42M | 0.05% |
284,122
-190
| -0.1% | -$3.18K |
|
275
Sea Limited
SE
$65.8B
| $6.4M | 0.05% |
59,671
-14,304
| -19% | -$1.04M |
|
Similar funds
PCH
N
TWC
FDCDDQ
NA
Calamos Advisors's Q2 2020 Portfolio in Review
As of Q2 2020, Calamos Advisors held 803 positions worth $14.1B, up 11% from $12.7B the previous quarter. Its ten largest holdings account for 20% of the portfolio.
Calamos Advisors withdrew a net $4.28B in Q2 2020, closing 98 positions and reducing 295 holdings. Its most notable exit was Allergan plc, an estimated $67M position sold in full.
By sector, the portfolio is most concentrated in Technology at 15% of assets, up from 14% a quarter earlier, followed by Healthcare and Consumer Discretionary.
Against the trend, Calamos Advisors opened a new position in Boston Scientific Corporation 5.50% Mandatory Convertible Preferred Stock, Series A worth $59.7M.
- Calamos Advisors's largest Q2 2020 buy was Boston Scientific Corporation 5.50% Mandatory Convertible Preferred Stock, Series A: 569,916 shares worth $59.7M.
- Calamos Advisors added most to RTX Corp in Q2 2020, an estimated $38.2M increase.
- Calamos Advisors's biggest Q2 2020 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $578M.
- Calamos Advisors fully exited Allergan plc in Q2 2020, selling an estimated $67M.
- Calamos Advisors's ten largest holdings make up 20% of its $14.1B portfolio in Q2 2020.
- Calamos Advisors opened 108 new positions and closed 98 in Q2 2020.
- Calamos Advisors's portfolio value rose 11% quarter-over-quarter to $14.1B.
Based on Calamos Advisors's 13F filing for Q2 2020, filed 27 Jul 2020.